Cite
HARVARD Citation
Santos, R. et al. (2022). Paediatric patients with heterozygous familial hypercholesterolaemia treated with evolocumab for 80 weeks (HAUSER-OLE): a single-arm, multicentre, open-label extension of HAUSER-RCT. Lancet. 10 (10), pp. 732-740. [Online].